Our Science – Liu Website
Yongmin Liu, M.D., Ph.D.
Subsequently, between 2001 and 2007, Dr. Liu worked as a research fellow in the Laboratory of Comparative Carcinogenesis, CCR. His work during this period of time focused on cancer prevention, particularly metabolic intervention of cancer. From 2007 to 2009, Dr. Liu served as a research scientist with SAIC-Frederick, Inc. He is currently a staff scientist with Dr. Miriam Poirier in the Carcinogen-DNA Interactions Section in the Laboratory of Cancer Biology and Genetics.
Dr. Liu's current studies focus on mitochondrial toxicity induced by anti-retroviral drugs and, in particular, nucleoside reverse transcriptase inhibitors (NRTIs). His projects include:
1) structural and functional mitochondrial changes in patas monkey fetuses exposed to human-equivalent antiretroviral protocols during gestation;
2) metabolic and bioenegetic consequences NRTIs exposures in cardiomyocytes and monkey tissues; and
3) the use of chemopreventive agents in reversal of NRTI-induced mitochondrial toxicity.
This page was last updated on 7/11/2014.